Ievgen Spasenenko

Dr. Ievgen Spasenenko

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Tomasz UrbanowiczTomasz Urbanowicz
Tomasz Urbanowicz
AHAnetta Hanć
Anetta Hanć
JFJulia Frąckowiak
Julia Frąckowiak
JPJakub Piecek
Jakub Piecek
ISIevgen Spasenenko
Ievgen Spasenenko
ATAndrzej Tykarski
Andrzej Tykarski
Background: Coronary artery disease (CAD) is a chronic inflammatory disease with multiple well-known risk factors. Although epidemiological studies report improvements in classical CAD risk-factor control, except for diabetes and obesity, cardiovascular diseases remain the leading causes of morbidity and mortality in the current population. The question regarding the atherosclerotic plaque location in particular arteries remains unanswered. Research on novel possible aspects that could help to properly understand atherosclerosis pathophysiology is essential. This study was based on a body trace-elements analysis, measured in scalp hair samples, as possible co-factors of various enzymes that may be crucial for CAD development. Methods: A total of 133 consecutive male patients with a median age of 71 (65–75) years, who presented with anginal symptoms of CCS class 2.0 (0.3) without previous heart-related interventions, were included in the analysis. The results of the cine-angiography were compared with the demographical, clinical, and laboratory results, followed by scalp-hair trace analysis. The possible predictors for coronary disease locations in the left descending artery (LAD), the circumflex artery (Cx), and the right coronary artery (RCA) were the subjects of this study. Results: Statistically significant differences in the scalp-hair trace elements concentration between the CAD and normal angiogram groups were noticed for magnesium (p = 0.003), calcium (p < 0.001), chromium (p = 0.011), and copper (p = 0.043). The multivariable analysis for epicardial atherosclerotic disease revealed the co-existence of diabetes mellitus (OR: 2.94, 95% CI: 1.27–6.79, p = 0.012) as a possible causative factor for the LAD location. The multivariable analysis for the atherosclerosis location in the Cx artery presented scalp-hair magnesium as a possible predictive factor (OR: 0.98, 95% CI: 0.96–1.00, p = 0.024). The multivariable model for the RCA location of atherosclerotic plaque indicated scalp-hair Zn concentration (0.99, 95% CI: 0.98–1.00, p = 0.002) and serum HDL (OR: 0.61, 95% CI: 0.04–0.09, p = 0.016). Conclusions: Possible hypothetical distinctive pathomechanisms, in particular, coronary artery involvement, in atherosclerosis processes are presented in the male group. Diabetes mellitus was found to be the primary factor for left descending artery disease. The low scalp-hair magnesium concentration was found to be a possible risk factor involved in the circumflex artery atherosclerotic plaque location. The inverse relation between serum high-density lipoprotein, the scalp hair zinc concentration, and right coronary disease was noticed.

Verified
Journal Article
Open access
PDF file
Tomasz UrbanowiczTomasz Urbanowicz
Tomasz Urbanowicz
PGPaweł Gutaj
Paweł Gutaj
SPSzymon Plewa
Szymon Plewa
ISIevgen Spasenenko
Ievgen Spasenenko
BKBeata Krasinska
Beata Krasinska
JMJan Matysiak
Jan Matysiak
Coronary artery atherosclerosis is a common condition characterized by different symptomatology and incidences of risk factors. The disease manifestation may differ; therefore, proper diagnosis is essential. The preventive, diagnostic, and therapeutic arms are still developing to improve patient outcomes. Among diagnostic steps, the non-invasive tools for evaluating non-classical factors related to metabolomic profiles are gaining attention. The aim of this study was to investigate possible metabolic profiling differences between patients with chronic coronary artery disease (CAD) and a control group based on plasma sphingomyelin levels. The study group consisted of 23 patients (72% male, median age of 69 (63–72) years) presenting with chronic coronary syndrome and confirmed epicardial disease in coronary angiography and 15 patients (33% male, median age of 70 (64–72) years) with normal angiographic results. Clinical data were recorded, and blood samples were collected for standard biochemical laboratory assessment and metabolomic profiling. The plasma sphingomyelin levels were evaluated in patients with different degrees of coronary artery atherosclerosis involvement. In addition, the severity of the epicardial disease was estimated by the Gensini Score. The study subgroups did not differ in terms of age (p = 0.765) and co-morbidities, though the male sex was more common in the CAD group (p = 0.007). The analysis revealed significant differences regarding neutrophil count (p = 0.014), neutrophil-to-lymphocyte ratio (NLR) (p = 0.016), and high-density lipoprotein (HDL) (p = 0.003). Among different plasma sphingomyelin species, there was a significant difference in plasma SM42:1 level (16.2 (14.2–19.1) vs. 20.8 (18.9–21.7) (p = 0.044) between the CAD and control groups, respectively. The SM 42:1 plasma level was independent of the number of involved epicardial arteries (p = 0.109). However, Spearman correlations tests were performed between the SM 42:1 plasma level and the number of coronary arteries diagnosed with atherosclerosis disease (rho = −0.356, p = 0.014) and the severity of the disease measured by the Gensini Score (rho = −0.403, p = 0.006). There was no correlation between plasma sphingomyelin levels and NLR (Spearman’s rho = −0.135, p = 0.420), suggesting a lack of inflammatory associations. Further, sphingomyelins showed no relationship with coronary artery disease risk factors such as dyslipidemia and diabetes. Lower plasma SM 42:1 levels were revealed in the CAD group compared with the control group, indicating a possible significance of sphingomyelin 42:1 in coronary artery disease progression.

Verified
Journal Article
Open access
PDF file
Tomasz UrbanowiczTomasz Urbanowicz
Tomasz Urbanowicz
AHAnetta Hanć
Anetta Hanć
ZKZofia Anna Kasperowicz
Zofia Anna Kasperowicz
OAOliwier Adamczak
Oliwier Adamczak
ISIevgen Spasenenko
Ievgen Spasenenko
BKBeata Krasinska
Beata Krasinska
Background: The pathophysiology of HFpEF is complex and characterized by systemic inflammation, metabolic dysregulation, and endothelial dysfunction. Trace element involvement in redox balance, mitochondrial function, and calcium signaling is postulated. This cross-sectional analysis aimed to investigate possible differences in hair scalp trace element concentrations in patients with HFpEF and controls. Material and methods: Fifty-eight consecutive patients were enrolled (HFpEF n = 37; controls n = 21). HFpEF diagnosis was established using the HFA-PEFF diagnostic algorithm by two independent cardiologists blinded to hair analysis results. Scalp hair samples were analyzed using inductively coupled plasma mass spectrometry (ICP-MS). Results: HFpEF patients demonstrated higher hair concentrations of magnesium (17.8 (7.3–47.5) vs. 14.0 (6.7–29.0) µg/g, p = 0.037), copper (57.24 (33.87–84.76) vs. 12.96 (9.85–26.02) µg/g, p < 0.001), calcium (322 (106–1330) vs. 145 (74–672) µg/g, p = 0.006), and lead (0.257 (0.164–0.563) vs. 0.159 (0.079–0.283) µg/g, p = 0.03). Conclusions: In this exploratory analysis, HFpEF was associated with differences in selected scalp hair trace element concentrations. The interaction between magnesium, calcium, copper, and lead were noted, with higher concentrations in HFpEF phenotypes. These findings are hypothesis-generating and warrant confirmation in larger cohorts incorporating serum/urine measurements and exposure assessment.

Verified
Journal Article
Open access
PDF file
Tomasz UrbanowiczTomasz Urbanowicz
Tomasz Urbanowicz
PGPaweł Gutaj
Paweł Gutaj
SPSzymon Plewa
Szymon Plewa
Anna Olasińska-WiśniewskaAnna Olasińska-Wiśniewska
Anna Olasińska-Wiśniewska
ISIevgen Spasenenko
Ievgen Spasenenko
JMJan Matysiak
Jan Matysiak
Coronary artery disease remains an epidemiological challenge as global morbidity is not declining despite the fact that the risk factors are well known. Metabolomic derivatives of atherosclerosis formation have recently gained attention as a possible non-traditional risk factor. The aim of this study was to find potential differences in acetyl-carnitine chain serum concentrations between epicardial artery disease patients and a control group. There were 41 patients (25 men and 16 women), with a median (Q1–Q3) age of 69 (63–73) years, enrolled in the prospective metabolomic analysis. They were divided into two groups based on cine angiography results confirming epicardial artery disease (group 1, n = 25 (61%)) or showing characteristics corresponding to normal angiograms (group 2, n = 16 (39%)). The quantitation of metabolites was performed based on the coronary angiograms. Significant differences related to the plasma concentration of L-Acetyl-carnitine (7.49 (4.79–9.23) µM vs. 9.36 (8.57–10.23) µM (p = 0.009)), Decanoyl-carnitine (0.00 (0.00–0.37) µM vs. 0.36 (0.19–0.44) µM (p = 0.040)), C12:1-carnitine (0.17 (0.14–0.20) µM vs. 0.22 (0.18–0.24) µM (p = 0.008)), trans-2-Dodecenoyl-carnitine (0.10 (0.07–0.13) µM vs. 0.13 (0.10–0.15) µM (p = 0.002)), cis-5-Tetradecenoyl-carnitine (0.03 (0.02–0.04) µM vs. 0.04 (0.03–0.05) µM (p = 0.043)), and 3,5-Tetradecadien-carnitine (0.16 (0.14–0.18) µM vs. 0.18 (0.17–0.27) µM (p = 0.007)) in group 1 vs. group 2 were noted. Increased plasma levels of acetyl-carnitine may be characteristic of patients with normal coronary angiograms.

25 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Tomasz UrbanowiczTomasz Urbanowicz
Tomasz Urbanowicz
DPDagmara Pietkiewicz
Dagmara Pietkiewicz
SPSzymon Plewa
Szymon Plewa
BKBeata Krasinska
Beata Krasinska
ISIevgen Spasenenko
Ievgen Spasenenko
ATAndrzej Tykarski
Andrzej Tykarski
Background: Coronary disease (CAD) is a multifactorial complex pathology characterized by excessive inflammatory activation and oxidative stress. Amino acids are among the potential biomarkers for cardiovascular pathology. The analysis aimed to investigate the possible relationship between proteomic profiling and coronary artery disease risk as novel markers of CAD. Methods: Patients with similar demographic and clinical profiles, including the prevalence of comorbidities such as arterial hypertension, dyslipidemia, and diabetes mellitus, were divided into two groups based on the results of their coronary angiograms. Serum amino acid levels were measured using liquid chromatography–tandem mass spectrometry. Results: Patients with significant coronary atherosclerosis confirmed in coronary angiograms were characterized by higher levels of circulating cystine, threonine, methionine, and proline. The number of involved coronary arteries in atherosclerotic processes revealed a correlation with circulating levels of threonine, methionine, and proline, not cystine. The multivariable logistic regression analysis for any significant coronary artery disease prediction revealed higher values of circulating threonine as a possible risk factor. Thereafter, a subanalysis was conducted to examine the relationship between amino acid levels and atherosclerotic risk in specific coronary arteries. The multivariate analysis revealed cystine and proline as potential risk factors for atherosclerosis of the left descending artery (LAD). Higher values of threonine were identified as a possible risk factor for atherosclerotic plaque location in the circumflex artery in multivariate regression analysis. Proline circulating levels were found to be prognostic for right coronary artery disease. Conclusions: Elevated circulating levels of amino acids, including cystine, threonine, methionine, and proline, were observed in patients with significant coronary artery disease in our exploratory pilot study. The high circulating amino acid levels can be predictive of coronary artery disease in our multivariate models.

23 April 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
BKBeata Krasinska
Beata Krasinska
Tomasz UrbanowiczTomasz Urbanowicz
Tomasz Urbanowicz
ISIevgen Spasenenko
Ievgen Spasenenko
Krzysztof J. FilipiakKrzysztof J. Filipiak
Krzysztof J. Filipiak
KBKrzysztof Bartuś
Krzysztof Bartuś
AHAnetta Hanć
Anetta Hanć
Background: Trace elements function as essential micronutrients involved in oxidative balance, mitochondrial activity, and cardiovascular metabolism. Cigarette smoking represents a significant source of toxic metals and may disrupt systemic trace element homeostasis. Alterations in micronutrient and metal balance may contribute to oxidative stress, endothelial dysfunction, and myocardial remodeling, which are central mechanisms in the pathogenesis of heart failure with preserved ejection fraction (HFpEF). This study aimed to investigate whether smokers with HFpEF exhibit distinct hair trace element profiles compared with smokers without HFpEF. Methods: In this prospective pilot study, scalp hair samples were collected from adults undergoing clinical evaluation for suspected cardiovascular disease. Trace element concentrations were determined using inductively coupled plasma mass spectrometry (ICP-MS). Participants were first stratified according to smoking status and subsequently, within the smoker subgroup, according to HFpEF diagnosis based on the Heart Failure Association Pre-test assessment, Echocardiography and natriuretic peptide score (HFA-PEFF) algorithm. Differences in trace element concentrations were analyzed using appropriate statistical tests, with multiple-comparison correction using the Benjamini–Hochberg false discovery rate (FDR). Active smoking was defined as ≥10 cigarettes per day for at least 1 year, and cumulative exposure was quantified in pack-years. Results: Fifty-eight participants were included, including 27 active smokers. In unadjusted analyses, several trace elements differed between smokers with HFpEF and those without HFpEF, including vanadium, lithium, aluminum, and copper. However, after FDR correction, only copper remained significantly elevated in smokers with HFpEF (q = 0.004). Hair copper concentrations were markedly higher in the HFpEF group compared with smokers without HFpEF. These differences were observed alongside echocardiographic features consistent with diastolic dysfunction and structural cardiac remodeling. Conclusions: In this hypothesis-generating pilot study, smokers with HFpEF demonstrated elevated hair copper concentrations, suggesting disturbances in trace element and micronutrient homeostasis. Altered copper metabolism may reflect oxidative stress-related cardiometabolic remodeling associated with HFpEF. These findings raise the hypothesis that cardiometabolic phenotype, rather than smoking exposure alone, may modulate trace element homeostasis in HFpEF; however, causal relationships cannot be established.